URGN
URGN
IL0011407140
UroGen Pharma Ltd.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.8B EUR
1.8B EUR
875.77M EUR
1.13B EUR
Enterprise Value
1.9B EUR
1.92B EUR
960.98M EUR
1.15B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
13.18x
--
--
--
Price to Sales
9.54x
9.53x
6.23x
12.65x
Price to Book
--
--
--
--
EV/Revenue
10.05x
10.15x
6.84x
12.84x
EV/EBITDA
-28.57x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-5.94%
-8.85%
-18.96%
-10.66%
ende